From USFDA
Panacea Biotec has received Establishment Inspection Report (EIR) from USFDA indicating formal closure of the cGMP and pre-approval inspection conducted by USFDA, at the company's Oncology Parenteral and Oral Solids Dosage formulations facility at Malpur, Baddi, Himachal Pradesh.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
